Excerpts

Ultra-High-Performance LC-QTOF-MS/MS Method Sample Analysis The LC-QTOF-MS/MS experiments were performed only for nominally significant compounds (T7 vs.

However, there is a clear trend that previous systemic therapy is associated with decreased survival (7.3 vs. 13.1 months in our study), which has been confirmed by other studies [ 22 ].

After BS, the levels of most of the mentioned AAs showed a trend of returning to the correct concentrations similar to that observed in the LC group ( Table 2 ).

FeNO was measured in 67.8% of children at 6 months of follow-up (median: 4, CI: 0.0–8.6 ppb), 74.4% at 12 months (median: 6.0, CI: 2.8–12.0 ppb), 83.5% at month 18 (median: 8.0, CI: 4.0–14.0 ppb) and 72.1% at the final visit (median: 8.5, CI: 4.4–14.5 ppb), suggesting an increasing trend with time/age in asthmatics.

A post-hoc subgroup analysis showed a trend of a reducing ALSFRS-R slope decline in patients with moderately severe disease progression [ 276 ].

The effect was greater in ECs from MM patients than in those from MGUS patients, although the difference was hardly significant ( Figure 4 E).

The potential implications of this concept may be significant.

However, it shows a slightly significant difference among the groups.

To prevent the exclusion of predictors with borderline significance, a p -value of 0.100 rather than 0.050 was used for the inclusion of variables in the multivariate model.

In DMD patients, a positive trend in improvement of muscle function, as well as other measured physical functions was observed after 48 weeks of ataluren treatment.

Patients that initially presented with DIE showed a trend to also subsequently present with DIE (29/54: 53.7%) at the next surgery.

Statistical significance was set at p < 0.05, while the p value of <0.1 was considered a statistical trend. 2.2.

Fenofibrate did not reduce, but induced an increasing trend in the intracellular lipid content of macrophages.

Similarly, the level of intracellular triglycerides in human macrophages did not decrease in the fenofibrate group, although it showed a trend towards an increase in intracellular triglyceride content in cells treated with fenofibrate ( Figure 2 d,e).

However, our study also suggests the relative plateau phase is relative indeed, as the TTV-levels show a decreasing trend after this first year which continues until a final stable phase develops after 24 months, and that high TTV levels are especially predictive of long-term adverse outcome if samples are taken after 24 months.

Comparing the histological samples of AK in every patient before and after MAL-PDT, we observed a marginally significant increase in VDR expression after the treatment in addition to the already know reduction in P53 and Ki67 expression [ 7 ].

However, an important trend was found towards the increase of the perfusion after the end of the artery clamping. 3.3.

During a median follow-up of 16 months, this subgroup of patients showed a trend towards lower rates of death or dependency (12.7% vs. 18.3%, hazard ratio (HR) 0.73, 95% CI 0.44–1.21) [ 2 ].

First, despite higher serological CMV risk, we noticed a clear trend of lower CMV incidence in the CMVIg subset (4% vs. 22.2%), which in view of well-known direct and indirect CMV-related harms could have been involved in superior outcome.

Only pre-LT elevated lactate level and absence of CMVIg therapy were identified as independent promoters of 3-month mortality, whereas cold ischemia time almost reached statistical significance ( Table 4 ).

Kaplan-Meier survival analysis of these cases resulted in a highly significant separation of the two predicted cohorts, with a median survival of 8.9 months for the predicted QM cases and of 39.8 months for the predicted non-QM cases (log-rank-test p < 0.0001, HR 4.33, 95% CI 1.41–13.32, Figure 4 ). 4.

While there was borderline significance for the increased rate of coronary artery perforations, the overall complications rate and puncture site bleedings in the TFA group when compared to TRA.

In univariate analysis, only GCC thickness showed a marginally significant correlation with postoperative VF recovery, but this was not significant in multivariate analysis.

In Figure 6 c, the dark pink bars show an increasing trend in not reporting the gender in their studies.

A probability value of p < 0.05 was considered significant, and of p < 0.01 highly significant.